<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02367573</url>
  </required_header>
  <id_info>
    <org_study_id>HUCH-328-150128</org_study_id>
    <nct_id>NCT02367573</nct_id>
  </id_info>
  <brief_title>3D vs 2D HD Laparoscopy in Inguinal Hernia Repair</brief_title>
  <official_title>3D Versus 2D HD Laparoscopy in Inguinal Hernia Repair: a Prospective, Single Blinded, Randomized, Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Helsinki University Central Hospital</source>
  <brief_summary>
    <textblock>
      Inguinal hernia can be repaired laparoscopically. In the normal laparoscopy there are only
      two-dimensional view, which is somewhat challenging when operating in three-dimensional
      environment. The three-dimensional laparoscopic systems are gradually entering the operating
      rooms. There are plenty of evidence of the benefits of 3D-system in laboratory conditions.
      However, no prospective randomized trials have been published in the clinical point of view.
      Therefore, the purpose of this study is to investigate is there something to gain in changing
      into 3D laparoscopic system in the transabdominal pre-peritoneal (TAPP) inguinal hernia
      repair.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of surgery</measure>
    <time_frame>Expected average time of surgery 1 hour</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Need for conversion into open surgery</measure>
    <time_frame>During the operation, expected average time of surgery 1 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative complications</measure>
    <time_frame>During the operation, expected average time of surgery 1 hour</time_frame>
    <description>Any complication during the operation e.g. hemorrhagic, intestine or bladder rupture</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications, Clavien-Dindo classification</measure>
    <time_frame>30 days after randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative stay in hospital</measure>
    <time_frame>Expected range 0-7 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding</measure>
    <time_frame>During the operation, expected average time of surgery 1 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with readmission(s)</measure>
    <time_frame>30 days after randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total need of opioids in milligrams</measure>
    <time_frame>Expected range 0-7 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>30 days after randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operation theatre time</measure>
    <time_frame>Expected average 1,5 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain, VAS</measure>
    <time_frame>Expected range 0-7 day</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Incisional hernias</measure>
    <time_frame>after 1, 5 and 10 year</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Inguinal hernia recurrence</measure>
    <time_frame>after 1, 5 and 10 year</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">274</enrollment>
  <condition>Hernia, Inguinal</condition>
  <arm_group>
    <arm_group_label>2D TAPP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Trans-abdominal pre-peritoneal laparoscopic inguinal hernia repair operated with two dimensional view</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3D TAPP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Trans-abdominal pre-peritoneal laparoscopic inguinal hernia repair operated with three dimensional view</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>2D laparoscopic TAPP inguinal hernia repair</intervention_name>
    <arm_group_label>2D TAPP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>3D laparoscopic TAPP inguinal hernia repair</intervention_name>
    <arm_group_label>3D TAPP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for laparoscopic inguinal hernia repair

        Exclusion Criteria:

          -  Some other surgical operation planned during TAPP

          -  Expected major risk of conversion (e.g. multiple previous abdominal operation,
             previous peritonitis)

          -  Operating surgeon experience less than 5 3D laparoscopy operations
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ville Sallinen, MD,PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Helsinki University Central Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Helsinki University Central Hospital</name>
      <address>
        <city>Helsinki</city>
        <zip>00029</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 9, 2015</study_first_submitted>
  <study_first_submitted_qc>February 12, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 20, 2015</study_first_posted>
  <last_update_submitted>May 6, 2018</last_update_submitted>
  <last_update_submitted_qc>May 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Helsinki University Central Hospital</investigator_affiliation>
    <investigator_full_name>Hanna Koppatz</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Inguinal</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

